Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on endothelin

D Stewart1

  • 1University of Toronto, St Michael's Hospital, Ontario.

The Canadian Journal of Cardiology
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Endothelin-1, a peptide from the endothelium, is implicated in heart failure. Endothelin antagonists may offer therapeutic value for this cardiovascular condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What supports hospital pharmacist prescribing in Scotland? - A mixed methods, exploratory sequential study.

Research in social & administrative pharmacy : RSAP·2017
Same author

A qualitative study of determinants of patient behaviour leading to an infection related hospital admission.

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

'When you are homeless, you are not thinking about your medication, but your food, shelter or heat for the night': behavioural determinants of homeless patients' adherence to prescribed medicines.

Public health·2017
Same author

OPTN/SRTR 2015 Annual Data Report: Early effects of the new kidney allocation system.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Factors associated with use of psychiatric intensive care and seclusion in adult inpatient mental health services.

Epidemiology and psychiatric sciences·2016
Same journal

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
Same journal

Practical approach to the assessment of technical scanning skills in transthoracic echocardiography.

The Canadian journal of cardiology·2026
Same journal

Cost-effectiveness of Pharmacist- and Nurse Practitioner-led Medication Management for Heart Failure With Reduced Ejection Fraction.

The Canadian journal of cardiology·2026
Same journal

Rethinking Pacing After Transcatheter Aortic Valve Implantation to Preserve Ventricular Function.

The Canadian journal of cardiology·2026
Same journal

High Intensity Interval Training Versus Moderate Continuous Training in Adults with Congenital Heart Disease: A Randomized Controlled Trial.

The Canadian journal of cardiology·2026
Same journal

Four-Chamber Myocardial Strain to Predict Mortality in Pulmonary Embolism.

The Canadian journal of cardiology·2026
See all related articles

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Background:

  • Endothelin is a potent vasoconstrictor peptide produced by vascular endothelial cells.
  • The endothelin system is activated in cardiovascular diseases like heart failure, myocardial infarction, and pulmonary hypertension.
  • Endothelin-1 (ET-1) is a key isoform suggested to mediate heart failure pathophysiology.

Purpose of the Study:

  • To review the role of the endothelin system in heart failure.
  • To evaluate the potential therapeutic value of endothelin antagonists in managing heart failure.

Main Methods:

  • Literature review of studies investigating the endothelin system in cardiovascular conditions.
  • Analysis of data concerning the pathophysiological effects of endothelin-1 in heart failure.

Related Experiment Videos

  • Review of clinical trial data on endothelin antagonists for heart failure treatment.

    • Main Results:

    • The endothelin system, particularly endothelin-1, plays a significant role in the development and progression of heart failure.
    • Evidence suggests that endothelin-1 contributes to vasoconstriction, cardiac remodeling, and fibrosis in heart failure.
    • Preclinical and clinical data indicate that endothelin antagonists can improve hemodynamic function and reverse adverse cardiac remodeling.

    Conclusions:

    • The endothelin system is a critical mediator in the pathophysiology of heart failure.
    • Endothelin antagonists represent a promising therapeutic strategy for patients with heart failure.
    • Targeting the endothelin pathway may offer a novel approach to managing cardiovascular disease.